Le Lézard
Classified in: Science and technology
Subject: CCA

Research Solutions to Announce Third Quarter Fiscal 2024 Results on Thursday, May 9, 2024


HENDERSON, Nev., April 30, 2024 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ: RSSS), a pioneer in providing cloud-based workflow solutions for R&D driven organizations, will hold a conference call to discuss its financial results for the fiscal 2024 third quarter ended March 31, 2024, on Thursday, May 9, 2024, at 5:00 p.m. ET. A press release containing the company's financial results will be issued following the market close and prior to the call.

Research Solutions President and CEO Roy W. Olivier and CFO Bill Nurthen will host the conference call, followed by a question and answer period.

Date: Thursday, May 9, 2024
Time: 5:00 p.m. ET (2:00 p.m. PT)
Dial-in number: 1-785-424-1699
Conference ID: RESEARCH

Please dial into the conference 5-10 minutes prior to the start time. An operator will register your name and organization. The conference call will be broadcast live and available for replay via the investor relations section of the company's website at http://researchsolutions.investorroom.com.

A replay of the conference call will be available after 8:00 p.m. ET on the same day through June 9, 2024. To access the replay, dial 1-412-317-6671 and use replay ID 11155728.

About Research Solutions

Research Solutions, Inc. (NASDAQ: RSSS) provides cloud-based technologies to streamline the process of accessing, managing, and creating intellectual property. Since its founding, the company has been a pioneer in developing solutions to serve researchers. Today, more than 70 percent of the top pharmaceutical companies, prestigious universities, and emerging businesses rely on our family of products, powered by AI and NLP technologies, to support the innovation process from end to end with the most comprehensive information and knowledge tools on the market. For more information and details, please visit www.researchsolutions.com 

SOURCE Research Solutions, Inc.


These press releases may also interest you

at 07:10
Veritone AI-Powered Solutions for Public Sector Now Available in AWS Marketplace
Veritone, Inc. , a leader in designing human-centered AI solutions, today announced that its public sector solutions are available in AWS Marketplace, a curated digital catalog of independent software vendors that make it easy to find, test, buy, and...

at 07:10
Anumana Demonstrates Global Readiness with Receipt of ISO 13485 Certification
Anumana, a leading AI-driven health technology company and portfolio company of nference, announced today that it has received the International Organization for Standardization (ISO) 13485 certification for its Quality Management System. This...

at 07:10
Advyzon Investment Management (AIM) Adds New Asset Managers, Including BlackRock and DFA
Advyzon Investment Management (AIM), a turnkey asset management program (TAMP) under the umbrella of comprehensive technology platform Advyzon, recently added multiple new asset managers and strategists to their platform, including BlackRock,...

at 07:10
Immervision Announces Advanced Image Quality Lab in Sofia to Provide Next-Level Imaging Services
In an era where visual technology is integral to innovation across industries, Immervision, a leader in wide-angle vision and imaging technology, unveils its advanced Image Quality (IQ) Lab in Sofia, Bulgaria. This strategic move comes as the demand...

at 07:10
ReposiTrak Welcomes a New Wholesaler to Rapidly Expanding Food Traceability Network
ReposiTrak , the world's leader in food traceability and regulatory compliance, leveraging its comprehensive inventory management and out-of-stock reduction SaaS platform, welcomes a new wholesaler to the ReposiTrak Traceability Network® (RTN). The...

at 07:10
PureTech Founded Entity Vedanta Biosciences Enrolls First Patient in Pivotal Phase 3 RESTORATiVE303 Study of VE303 for the Prevention of Recurrent C. difficile Infection
PureTech Health plc ("PureTech" or the "Company"), a clinical-stage biotherapeutics company, noted today that its Founded Entity, Vedanta Biosciences, a clinical-stage company that is developing a potential new category of oral therapies based on...

More news about Science and technology...


News published on and distributed by: